G-Protein Coupled Receptors (GPCRs)
1. Introduction
G-Protein Coupled Receptors (GPCRs), also known as Seven-Transmembrane (7TM)
receptors, constitute the largest and most diverse family of membrane receptors in eukaryotes.
They act as molecular mailboxes, detecting specific agents outside the cell (ligands) and
activating internal signal transduction pathways that produce cellular responses.
Key Characteristics:
● Abundance: Encoded by over 800 genes in the human genome.
● Ligand Diversity: They bind a vast array of ligands, including photons (light), odors,
pheromones, hormones, and neurotransmitters.
● Location: Found essentially on the plasma membrane of all eukaryotic cells.
2. Structure
The structural architecture of GPCRs is highly conserved across the family.
● 7-Transmembrane Domain: The core consists of a single polypeptide chain that threads
back and forth across the lipid bilayer seven times, forming seven hydrophobic
\alpha-helices (TM1 to TM7).
● Extracellular Region:
○ N-Terminus: Located outside the cell; often involved in ligand recognition or
binding.
○ Extracellular Loops (ECLs): Three loops (ECL1–3) connect the transmembrane
helices on the outer side.
● Intracellular Region:
○ C-Terminus: Located inside the cell; interacts with downstream signaling proteins
(like G-proteins and \beta-arrestins).
○ Intracellular Loops (ICLs): Three loops (ICL1–3) vital for G-protein coupling.
3. The Heterotrimeric G-Protein
GPCRs function by interacting with G-proteins (Guanine nucleotide-binding proteins) located
on the intracellular side of the membrane. These G-proteins are heterotrimeric, meaning they
are composed of three distinct subunits:
1. \alpha (Alpha) Subunit: Binds GDP (inactive) or GTP (active). It possesses intrinsic
GTPase activity (can hydrolyze GTP back to GDP).
2. \beta (Beta) Subunit: Forms a stable dimeric complex with the \gamma subunit.
3. \gamma (Gamma) Subunit: Anchored to the cell membrane via lipid modification.
4. Mechanism of Action
The signaling cycle involves a series of conformational changes:
1. Resting State: The GPCR is unoccupied. The G-protein \alpha-subunit is bound to GDP
and is associated with the \beta\gamma dimer.
2. Ligand Binding: An agonist (hormone, neurotransmitter) binds to the extracellular side of
the GPCR.
3. Conformational Change: The receptor undergoes a shape change that allows it to act
as a Guanine Nucleotide Exchange Factor (GEF) for the G-protein.
4. Activation: The GPCR induces the \alpha-subunit to release GDP and bind GTP.
5. Dissociation: Binding of GTP destabilizes the heterotrimer. The \alpha-GTP subunit
dissociates from the \beta\gamma dimer. Both the \alpha-GTP and \beta\gamma
complex are now active and can regulate downstream effectors (enzymes or ion
channels).
6. Termination: The \alpha-subunit hydrolyzes its bound GTP to GDP (via intrinsic GTPase
activity). The \alpha-GDP subunit re-associates with the \beta\gamma dimer, returning the
system to the resting state.
5. Major Signaling Pathways
The specific cellular response depends on which type of G$\alpha$ subunit is activated.
A. The cAMP Signaling Pathway (Gs and Gi)
● Gs (Stimulatory):
1. Ligand binds \rightarrow activates G$\alpha_s$.
2. G$\alpha_s$ stimulates Adenylyl Cyclase (AC).
3. AC converts ATP into cyclic AMP (cAMP) (Second Messenger).
4. High cAMP levels activate Protein Kinase A (PKA).
5. PKA phosphorylates target proteins (e.g., enzymes, ion channels) and transcription
factors like CREB, altering gene expression.
● Gi (Inhibitory):
1. Activates G$\alpha_i$.
2. Inhibits Adenylyl Cyclase.
3. Decreases cAMP levels, opposing the effects of Gs.
B. The Phosphatidylinositol Pathway (Gq)
● Gq:
1. Ligand binds \rightarrow activates G$\alpha_q$.
2. G$\alpha_q$ activates Phospholipase C (PLC).
3. PLC cleaves the membrane lipid PIP$_2$ into two second messengers:
■ IP$_3$ (Inositol 1,4,5-trisphosphate): Soluble molecule that diffuses to the
Endoplasmic Reticulum (ER) and opens Ca$^{2+}$ channels, releasing
stored Calcium.
■ DAG (Diacylglycerol): Remains in the membrane and activates Protein
Kinase C (PKC).
4. Increased Ca$^{2+}$ and PKC activation lead to cellular responses (e.g., smooth
muscle contraction).
6. Physiological Roles
GPCRs regulate virtually every aspect of human physiology:
1. Sensory Perception:
○ Vision: Rhodopsin (a GPCR) detects photons in the retina.
○ Smell & Taste: Olfactory and gustatory receptors detect chemical odorants and
tastants.
2. Neurotransmission: Receptors for dopamine, serotonin, glutamate, and GABA modulate
mood, cognition, and synaptic transmission.
3. Immune System: Chemokine receptors guide the migration of immune cells to sites of
infection/inflammation.
4. Autonomic Nervous System: Adrenergic receptors regulate heart rate and blood
pressure.
5. Endocrine Function: Receptors for TSH, LH, FSH, and ACTH regulate hormone release.
7. Clinical Significance
GPCRs are the most successful class of drug targets in modern pharmacology. Approximately
30% to 50% of all marketed drugs target GPCRs.
Drug Class Target GPCR Indication
Beta-blockers (e.g., \beta-Adrenergic Receptors Hypertension, Heart Failure
Propranolol)
Antihistamines (e.g., H$_1$ Histamine Receptor Allergies
Loratadine)
Opioids (e.g., Morphine) \mu-Opioid Receptor Pain Management
Bronchodilators (e.g., \beta_2-Adrenergic Receptor Asthma
Albuterol)
Anti-psychotics (e.g., Dopamine/Serotonin Receptors Schizophrenia
Clozapine)
Diseases associated with GPCR mutations:
● Nephrogenic Diabetes Insipidus: Mutation in Vasopressin V2 receptor.
● Retinitis Pigmentosa: Mutations in Rhodopsin.
● Whooping Cough & Cholera: Bacterial toxins (Pertussis and Cholera toxins) chemically
modify G-proteins, locking them in "off" or "on" states, leading to disease symptoms.